Central adiposity and decreased heart rate variability in postmenopause: a cross-sectional study

References

• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012;125:e2–e220
   PubMed Web of Science ®Google Scholar
• Schenck-Gustafsson K. Risk factors for cardiovascular disease in women. Maturitas 2009;63:186–90
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–7
   PubMed Web of Science ®Google Scholar
• Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997;66:111–15
   PubMed Web of Science ®Google Scholar
• You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004;89:5517–22
   PubMed Web of Science ®Google Scholar
• Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006;13:280–5
   PubMed Web of Science ®Google Scholar
• Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010;95:5419–26
   PubMed Web of Science ®Google Scholar
• Dube MC, Lemieux S, Piche ME, et al. The contribution of visceral adiposity and mid-thigh fat-rich muscle to the metabolic profile in postmenopausal women. Obesity (Silver Spring) 2011;19:953–9
   PubMed Web of Science ®Google Scholar
• Smith JD, Borel AL, Nazare JA, et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 2012;97:1517–25
   PubMed Web of Science ®Google Scholar
• Zhu S, Wang Z, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the Third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002;76:743–9
   PubMed Web of Science ®Google Scholar
• Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460–8
   PubMed Web of Science ®Google Scholar
• Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008;57:961–5
   PubMed Web of Science ®Google Scholar
• Creatsa M, Armeni E, Stamatelopoulos K, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 2012;61:193–201
   PubMed Web of Science ®Google Scholar
• Maturana MA, Moreira RM, Spritzer PM. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women. Maturitas 2011;70:395–9
   PubMed Web of Science ®Google Scholar
• Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003;108:1688–93
   PubMed Web of Science ®Google Scholar
• Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex- hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242–9
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–62
   PubMed Web of Science ®Google Scholar
• Moore RK, Groves DG, Barlow PE, et al. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 2006;8:585–90
   PubMed Web of Science ®Google Scholar
• Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 1996;27:270–6
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing. and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043–65
   PubMed Web of Science ®Google Scholar
• Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996;94:2850–5
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005;10:88–101
   PubMed Web of Science ®Google Scholar
• Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998;21:2116–22
   PubMed Web of Science ®Google Scholar
• Gianaros PJ, Salomon K, Zhou F, et al. A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women. Psychosom Med 2005;67:553–60
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979–85
   PubMed Web of Science ®Google Scholar
• Lauer MS. Autonomic function and prognosis. Cleveland Clin J Med 2009;76:S18–22
   Google Scholar
• Tsuji H, Venditti FJ Jr, Manders ES, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994;90:878–83
   PubMed Web of Science ®Google Scholar
• Brockbank CL, Chatterjee F, Bruce SA, Woledge RC. Heart rate and its variability change after the menopause. Exp Physiol 2000;85:327–30
   PubMed Web of Science ®Google Scholar
• Earnest CP, Lavie CJ, Blair SN, Church TS. Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLoS One 2008;3:e2288
   PubMed Web of Science ®Google Scholar
• Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 2007;56:992–7
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206–52
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
   PubMed Web of Science ®Google Scholar
• Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009;24:1726–31
   PubMed Web of Science ®Google Scholar
• Di Domenico K, Wiltgen D, Nickel FJ, et al. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?Fertil Steril 2012 Sep 28. pii: S0015-0282(12)02137-1. doi: 10.1016/j.fertnstert.2012.08.049. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Polanczyk CA, Rohde LE, Moraes RS, et al. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability. Eur J Appl Physiol Occup Physiol 1998;79:69–73
   PubMed Web of Science ®Google Scholar
• Renaud P, Blondin JP. The stress of Stroop performance: physiological and emotional responses to color-word interference, task pacing, and pacing speed. Int J Psychophysiol 1997;27:87–97
   PubMed Web of Science ®Google Scholar
• Delaney JP, Brodie DA. Effects of short-term psychological stress on the time and frequency domains of heart-rate variability. Percept Mot Skills 2000;91:515–24
   PubMed Web of Science ®Google Scholar
• MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991;109:163–203
   PubMed Web of Science ®Google Scholar
• Windham BG, Fumagalli S, Ble A, et al. The relationship between heart rate variability and adiposity differs for central and overall adiposity. J Obes 2012;2012:149516
   PubMedGoogle Scholar
• Antelmi I, de Paula RS, Shinzato AR, et al. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol 2004;93:381–5
   PubMed Web of Science ®Google Scholar
• Acharya UR, Kannathal N, Sing OW, Ping LY, Chua T. Heart rate analysis in normal subjects of various age groups. Biomed Eng Online 2004;3:24
   PubMed Web of Science ®Google Scholar
• Ribeiro TF, Azevedo GD, Crescencio JC, et al. Heart rate variability under resting conditions in postmenopausal and young women. Braz J Med Biol Res 2001;34:871–7
   PubMed Web of Science ®Google Scholar
• De Meersman RE, Stein PK. Vagal modulation and aging. Biol Psychol 2007;74:165–73
   PubMed Web of Science ®Google Scholar
• Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003;285:H2188–93
   PubMed Web of Science ®Google Scholar
• Chao HT, Kuo CD, Su YJ, et al. Short-term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women. Fertil Steril 2005;84:1477–83
   PubMed Web of Science ®Google Scholar
• Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. Pacing Clin Electrophysiol 2005;28:S172–7
   Google Scholar
• Zuanetti G, Neilson JM, Latini R, et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto Miocardico. Circulation 1996;94:432–6
   PubMed Web of Science ®Google Scholar
• Walsh D, Nelson KA. Autonomic nervous system dysfunction in advanced cancer. Support Care Cancer 2002;10:523–8
   PubMed Web of Science ®Google Scholar
• Fadul N, Strasser F, Palmer JL, et al. The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage 2010;39:283–90
   PubMed Web of Science ®Google Scholar
• Hildreth CM. Prognostic indicators of cardiovascular risk in renal disease. Front Physiol 2011;2:121
   PubMedGoogle Scholar
• Liao D, Cai J, Brancati FL, et al. Association of vagal tone with serum insulin, glucose, and diabetes mellitus – The ARIC Study. Diabetes Res Clin Pract 1995;30:211–21
   PubMed Web of Science ®Google Scholar
• Perini R, Milesi S, Fisher NM, Pendergast DR, Veicsteinas A. Heart rate variability during dynamic exercise in elderly males and females. Eur J Appl Physiol 2000;82:8–15
   PubMed Web of Science ®Google Scholar
• Colpani V, Oppermann K, Spritzer PM. Association between habitual physical activity and lower cardiovascular risk in pre-, peri- and postmenopausal women: a population-based study. Menopause 2012 Nov 19. Epub ahead of print
   Google Scholar
• Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol 2012;59:665–72
   PubMed Web of Science ®Google Scholar
• Mesch VR, Siseles NO, Maidana PN, et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008;11:509–17
   PubMed Web of Science ®Google Scholar
• Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492–7
   PubMed Web of Science ®Google Scholar
• Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010; 95:2038–49
   PubMed Web of Science ®Google Scholar
• Wiltgen D, Spritzer PM. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril 2010;94:2493–6
   PubMed Web of Science ®Google Scholar
• Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009;94:4776–84
   PubMed Web of Science ®Google Scholar
• Maturana MA, Spritzer PM. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 2002;51:238–43
   PubMed Web of Science ®Google Scholar
• Maturana MA, Rubira MC, Consolim-Colombo F, Irigoyen MC, Spritzer PM. Androgenicity and venous endothelial function in post-menopausal women. J Endocrinol Invest 2010;33: 239–43
   PubMed Web of Science ®Google Scholar
• Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991;20:151–6
   PubMed Web of Science ®Google Scholar
• Liedtke S, Schmidt ME, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012;20:1088–95
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women’s Health Across the Nation. Arch Intern Med 2008;168:1568–75
   PubMed Web of Science ®Google Scholar
• Elbers JM, Giltay EJ, Teerlink T, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 2003;58:562–71
   PubMed Web of Science ®Google Scholar
• Wildman RP, Tepper PG, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from The Study of Women’s Health Across the Nation. J Clin Endocrinol Metab 2012;97:E1695–704
   PubMed Web of Science ®Google Scholar